OPNT insider filings

OPIANT PHARMACEUTICALS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-03. Screen OPNT transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for OPNT between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — OPIANT PHARMACEUTICALS, INC.

FiledFormInsiderReported transactionsSource
2023-03-034Silver Gabrielle Alison — DirectorDisposition to issuer (D): 21,343 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0EDGAR
2023-03-034Ruth Matthew R. — Chief Commercial OfficerDisposition to issuer (D): 19,250 @ $20 · Disposition to issuer (D): 10,666 @ $20 · Grant/award (A): 2,000 @ $0 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 50,000 (derivative) @ $0EDGAR
2023-03-034Daly Richard J — DirectorDisposition to issuer (D): 5,800 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0EDGAR
2023-03-034CRYSTAL ROGER — Chief Executive Officer, Director, 10% ownerDisposition to issuer (D): 37,438 @ $20 · Disposition to issuer (D): 37,901 @ $20 · Disposition to issuer (D): 5,100 @ $20 · Grant/award (A): 6,667 @ $0 · Disposition to issuer (D): 6,667 @ $20 · Disposition to issuer (D): 25,000 (derivative) @ $0 · +6 moreEDGAR
2023-03-034Ellison Mark Jason Heath — Chief Development OfficerDisposition to issuer (D): 7,015 @ $20 · Disposition to issuer (D): 11,736 @ $20 · Disposition to issuer (D): 9,680 @ $20 · Grant/award (A): 2,000 @ $0 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 7,200 (derivative) @ $0 · +2 moreEDGAR
2023-03-034Sinclair Michael — Director, 10% ownerDisposition to issuer (D): 27,450 @ $20 · Disposition to issuer (D): 22,720 @ $20 · Disposition to issuer (D): 40,000 @ $20 · Disposition to issuer (D): 100,000 (derivative) @ $0 · Disposition to issuer (D): 250,000 (derivative) @ $0 · Disposition to issuer (D): 75,000 (derivative) @ $0EDGAR
2023-03-034MacDougall Ann L. — DirectorDisposition to issuer (D): 26,179 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0EDGAR
2023-03-034Lorianne Masuoka K. — DirectorDisposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Grant/award (A): 5,000 (derivative) @ $0EDGAR
2023-03-034Gorman BrianDisposition to issuer (D): 14,540 @ $20 · Disposition to issuer (D): 17,450 @ $20 · Grant/award (A): 2,000 @ $0 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 36,500 (derivative) @ $0 · Disposition to issuer (D): 10,750 (derivative) @ $0EDGAR
2023-03-034Thomas Thomas T. — DirectorDisposition to issuer (D): 10,375 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0EDGAR
2023-03-034O'Toole David D — Chief Financial OfficerDisposition to issuer (D): 22,512 @ $20 · Disposition to issuer (D): 11,736 @ $20 · Grant/award (A): 2,000 @ $0 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 33,000 (derivative) @ $0 · Disposition to issuer (D): 8,250 (derivative) @ $0 · +1 moreEDGAR
2023-03-034Collard Craig A — DirectorDisposition to issuer (D): 53,822 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0EDGAR
2023-03-034Skolnick Phil — Chief Scientific OfficerDisposition to issuer (D): 9,812 @ $20 · Disposition to issuer (D): 11,736 @ $20 · Grant/award (A): 2,000 @ $0 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 40,000 (derivative) @ $0 · Disposition to issuer (D): 13,200 (derivative) @ $0 · +2 moreEDGAR
2023-01-314CRYSTAL ROGER — Chief Executive Officer, Director, 10% ownerSale (S): 1,358 @ $20.26EDGAR
2023-01-314Ellison Mark Jason Heath — Chief Development OfficerSale (S): 610 @ $20.26EDGAR
2023-01-314Gorman BrianSale (S): 444 @ $20.26EDGAR
2023-01-314O'Toole David D — Chief Financial OfficerSale (S): 541 @ $20.26EDGAR
2023-01-314Skolnick Phil — Chief Scientific OfficerSale (S): 480 @ $20.26EDGAR
2023-01-094O'Toole David D — Chief Financial OfficerSale (S): 415 @ $20.20EDGAR
2023-01-094Ellison Mark Jason Heath — Chief Development OfficerSale (S): 469 @ $20.20EDGAR
2023-01-094CRYSTAL ROGER — Chief Executive Officer, Director, 10% ownerSale (S): 1,183 @ $20.20EDGAR
2023-01-094Skolnick Phil — Chief Scientific OfficerSale (S): 369 @ $20.20EDGAR
2023-01-054Ellison Mark Jason Heath — Chief Development OfficerSale (S): 1,806 @ $20.20EDGAR
2023-01-054O'Toole David D — Chief Financial OfficerSale (S): 1,600 @ $20.20EDGAR
2023-01-054Gorman BrianSale (S): 1,313 @ $20.20EDGAR
2023-01-054CRYSTAL ROGER — Chief Executive Officer, Director, 10% ownerSale (S): 5,029 @ $20.20EDGAR
2023-01-054Skolnick Phil — Chief Scientific OfficerSale (S): 1,421 @ $20.20EDGAR
2022-07-214Ruth Matthew R. — Chief Commercial OfficerSale (S): 1,084 @ $10.62EDGAR
2022-07-154O'Toole David D — Chief Financial OfficerSale (S): 779 @ $11.10EDGAR
2022-07-154Gorman BrianSale (S): 691 @ $11.16EDGAR
2022-07-154CRYSTAL ROGER — Chief Executive Officer, Director, 10% ownerSale (S): 2,246 @ $11.11EDGAR
2022-07-154Skolnick Phil — Chief Scientific OfficerSale (S): 627 @ $11.85EDGAR
2022-06-294Ellison Mark Jason Heath — Chief Development OfficerGrant/award (A): 2,000 @ $0EDGAR
2022-06-294CRYSTAL ROGER — Chief Executive Officer, Director, 10% ownerGrant/award (A): 6,667 @ $0EDGAR
2022-06-294O'Toole David D — Chief Financial OfficerGrant/award (A): 2,000 @ $0EDGAR
2022-06-294Gorman BrianGrant/award (A): 2,000 @ $0EDGAR
2022-06-294Ruth Matthew R. — Chief Commercial OfficerGrant/award (A): 2,000 @ $0EDGAR
2022-06-294Skolnick Phil — Chief Scientific OfficerGrant/award (A): 2,000 @ $0EDGAR
2022-06-154Sinclair Michael — Director, 10% ownerSale (S): 5,491 @ $11.09 · Sale (S): 7,225 @ $10.90 · Sale (S): 900 @ $10.60EDGAR
2022-06-144Daly Richard J — DirectorGrant/award (A): 2,000 @ $0EDGAR
2022-06-144Lorianne Masuoka K. — DirectorGrant/award (A): 2,000 @ $0EDGAR
2022-06-144MacDougall Ann L. — DirectorGrant/award (A): 2,000 @ $0EDGAR
2022-06-144Silver Gabrielle Alison — DirectorGrant/award (A): 2,000 @ $0EDGAR
2022-06-144Thomas Thomas T. — DirectorGrant/award (A): 2,000 @ $0EDGAR
2022-06-144Collard Craig A — DirectorGrant/award (A): 2,000 @ $0EDGAR
2022-06-134Sinclair Michael — Director, 10% ownerSale (S): 7,896 @ $12.25EDGAR
2022-06-134Collard Craig A — DirectorPurchase (P): 1,663 @ $11.50 · Purchase (P): 4,037 @ $10.94EDGAR
2022-06-084Sinclair Michael — Director, 10% ownerSale (S): 7,688 @ $12.94 · Sale (S): 800 @ $12.86EDGAR
2022-06-064Sinclair Michael — Director, 10% ownerSale (S): 9,736 @ $13.88 · Sale (S): 10,264 @ $13.59EDGAR
2022-06-064Gorman BrianSale (S): 1,148 @ $13.52EDGAR

Recent 8-K events — OPIANT PHARMACEUTICALS, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-03-028-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-018-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2023-02-278-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-02-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2022-11-158-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-08-118-K9.01 — Financial Statements and ExhibitsEDGAR
2022-06-148-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2022-06-088-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=OPNT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs